ARTEMISMED Q4 FY26 Guidance vs Delivery (ARTEMISMED Management Mirror)

Did ARTEMISMED's management deliver what it guided? Guidance vs actual performance and tone changes across recent earnings calls, as of the Q4 FY26 (Mar-2026 Qtr) concall.

  • ARTEMISMED Financials
  • ARTEMISMED Shareholding Pattern
  • ARTEMISMED Earnings Documents
  • ARTEMISMED Announcements
  • ARTEMISMED Corporate Actions
  • ARTEMISMED Bulk, Block & Insider Deals
  • ARTEMISMED Delivery Data
  • ARTEMISMED Earnings Concalls
  • Market Timeline
  • Concall Monitor
  • Company Research
  • Earnings Monitor
  • Upcoming Results
  • Sector Monitor
  • Sector Performance
  • Bulk & Block Deals
  • Delivery Data
  • FII & DII Activity
  • Market Indices
  • Plans & Pricing

Artemis Medicare Services Ltd (ARTEMISMED) Q4FY26 Management Mirror - Mar-2026 Qtr

Capacity & Capital Allocation

Management maintains its target to reach 2,000 beds by Mar'29, refining the Dec'25 Qtr estimate of 2,000 to 2,300 beds, supported by an approved INR 700 crore fundraise; peak debt guidance was restored to a maximum of INR 350 crores in the Mar'26 Qtr after briefly targeting below INR 300 crores in the Dec'25 Qtr, with new project deployments targeting a 16% to 18% ROCE over 3 to 5 years. [Status: Reaffirmed]

4 more themes on the ELITE plan.

  • ARTEMISMED Q4FY26 Concall Summary
  • ARTEMISMED Q4FY26 Concall Transcript
  • ARTEMISMED Q3FY26 Management Mirror (Dec-2025 Qtr)
  • ARTEMISMED Q1FY27 Management Mirror (Jun-2026 Qtr)